Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: vaccination

Exploring the Role of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus

Katie Robinson  |  October 25, 2024

An understanding of the mechanisms underlying NET-mediated inflammation will empower clinicians to target therapies that can mitigate disease activity & improve outcomes in patients with lupus.

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:ImmunologySLE Resource Center

Personalize Your Pediatric Lupus Care

Keri Losavio  |  September 26, 2024

On Nov. 16, the ACR Convergence 2024 session Toward Personalized Medicine in Pediatric Lupus will present important recent findings in the pathophysiology of pediatric lupus. Virginia Pascual, MD, is program director of an NIAID-funded Autoimmunity Center of Excellence and a NIAMS-funded Center for Lupus Research at Weill Cornell Medical College, New York. Her laboratory is…

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024ACR Convergence 2024 SLE

Plan Ahead: Clinical Tips for Managing Reproductive Health in Patients with Rheumatic Disease

Jason Liebowitz, MD, FACR  |  September 24, 2024

Dr. May Ching Soh highlighted practical approaches when caring for pregnant patients with rheumatic disease.

Filed under:ConditionsMeeting Reports Tagged with:APLARAPLAR 2024Asia Pacific League of Associations for Rheumatology (APLAR)pregnancypregnancy complicationspregnant women

Editor's Pick

B Cell-Depleting Therapy in SLE

Katie Robinson  |  September 19, 2024

“SLE has long been a disease with many clinical manifestations but few treatment options,” says Physician Editor Bharat Kumar, explaining why he thinks this article is a must-read. “That’s rapidly changing with advances in our knowledge of lupus, especially in the role of B-cells in triggering the onset and perpetuating disease activity of lupus.”

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Editor's PickImmunologySLE Resource Center

ACR Comments on 2025 Physician Fee Schedule

From the College  |  September 6, 2024

The ACR’s response to the Centers for Medicare & Medicaid Services addresses the likely harm of the proposed conversion factor on the solvency and stability of rheumatology practices. The comments also include recommendations on complex drug administration coding, inflation-adjusted drug rebates and extending telehealth flexibilities.

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR advocacyMedicare Physician Fee Schedule (MPFS)

Summary of Notable Provisions in CY 2025 Medicare PFS Proposed Rule

From the College  |  July 19, 2024

The ACR will provide comments on several provisions related to Medicare physician payment and the Quality Payment Program.

Filed under:Legislation & AdvocacyPractice Support Tagged with:Medicare Physician Fee Schedule (MPFS)Medicare ReimbursementQuality Payment Program (QPP)

Reflecting on B Cell-Depleting Therapies & COVID-19

Vanessa Caceres  |  March 6, 2024

In the early days of the COVID-19 pandemic, confusion and concern for immunosuppressed patients grew among rheumatologists and patients alike. Research has helped bridge the knowledge gap, and treatment options for COVID-19 have helped ease concerns.

Filed under:ConditionsDrug Updates Tagged with:COVID-19

What Every Clinician Should Know about Ramadan & Intermittent Fasting

Mohammad A. Ursani, MD, FACP, RhMSUS, Iman Qaiser, MD, & Mamdouh Mahmoud, PhD  |  February 7, 2024

Intermittent fasting—defined as alternating between cycles of eating and going without food over a given period of time—has become popular with individuals seeking to lose weight or balance their lifestyle in recent years. During Ramadan (a period based on the Gregorian calendar that changes from year to year), able-bodied Muslims are obligated to observe a…

Filed under:OpinionPatient Perspective Tagged with:adherencefastingintermittent fasting

The Future of SLE Treatment?

Ruth Jessen Hickman, MD  |  January 22, 2024

Georg Schett, MD, presented the latest research into CAR T cell therapy for rheumatic diseases, such as systemic lupus erythematosus & other conditions. These findings demonstrate remarkable and durable efficacy for the treatment, as well as the potential for disease remission in some patients.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:ACR Convergence 2023CAR-T cell therapyT cell

Pediatric Clinical Year in Review: 2023

Samantha C. Shapiro, MD  |  November 29, 2023

SAN DIEGO—Too many excellent pediatric rheumatology studies to squeeze into one talk? What a good problem to have. Dr. Ardoin first highlighted baricitinib in juvenile idiopathic arthritis.

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2023

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 24
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences